Search
for
Sort by
Research 571–600 of 1000+
- Expression and Function of Group IIE Phospholipase A2 in Mouse Skin
- Wharton’s jelly-derived mesenchymal stem cells in the treatment of four patients with alopecia areata
- Immune therapies for alopecia areata: evidence and new perspectives
- The Spectrum of Cutaneous Manifestations in Lupus Erythematosus: A Comprehensive Review
- An Updated in the Management of Alopecia Areata
- Asebia-2J (Scd1ab2J): A New Allele and a Model for Scarring Alopecia
- Hair follicle immune privilege and its collapse in alopecia areata
- Ichthyosis follicularis, alopecia, and photophobia (IFAP) syndrome
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Keratins as an Inflammation Trigger Point in Epidermolysis Bullosa Simplex
- Medical aesthetics – Current trends and a review of its applications
- Pili Torti: A Feature of Numerous Congenital and Acquired Conditions
- RSPO1-mutated keratinocytes from palmoplantar keratoderma display impaired differentiation, alteration of cell–cell adhesion, EMT-like phenotype and invasiveness properties: implications for squamous cell carcinoma susceptibility in patients with 46XX disorder of sexual development
- The Use of Imaging Techniques in the Diagnosis of Dermatoses of the Scalp
- A Current Diagnostic and Therapeutic Challenge: Tinea Capitis
- 549 Temporary cell cycle arrest in human scalp hair follicles and their epithelial stem cells by ALRN-6924: A novel strategy to selectively protect p53-wildtype cells against paclitaxel-induced alopecia
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Bioactive Nutritional Macromolecules Supporting Hair Structure, Density, and Growth: A Comprehensive Review
- Hair restoration surgery: pre-surgical considerations and pitfalls
- Regenerative medicine in the treatment of specific dermatologic disorders: a systematic review of randomized controlled clinical trials
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Trichoscopy pattern in alopecia areata: A systematic review and meta‐analysis
- Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?
- Annual Convention in the Time of COVID
- WNT10A mutation causes ectodermal dysplasia by impairing progenitor cell proliferation and KLF4-mediated differentiation
- Keratins and disease at a glance
- Keratins 6, 16, and 17 in Health and Disease: A Summary of Recent Findings
- Trichoscopy as a diagnostic tool in trichorrhexis invaginata and Netherton syndrome
- Ischemic modified albumin as a new biomarker in predicting of oxidative stress in alopecia areata
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata